Contraction is the primary function of adult arterial smooth muscle. However, in response to vessel injury or inflammation, arterial smooth muscle is able to phenotypically modulate from the contractile state to several ‘synthetic' states characterized by proliferation, migration and/or increased cytokine secretion. We examined the effect of tissue length (L) on the phenotype of intact, isometrically held, initially contractile swine carotid artery tissues. Tissues were studied (1) without prolonged incubation at the optimal length for force generation (1.0 Lo, control), (2) with prolonged incubation for 17 h at 1.0 Lo, or (3) with prolonged incubation at slack length (0.6 Lo) for 16 h and then restoration to 1.0 Lo for 1 h. Prolonged incubation at 1.0 Lo minimally reduced the contractile force without substantially altering the mediators of contraction (crossbridge phosphorylation, shortening velocity or stimulated actin polymerization). Prolonged incubation of tissues at slack length (0.6 Lo), despite return of length to 1.0 Lo, substantially reduced contractile force, reduced crossbridge phosphorylation, nearly abolished crossbridge cycling (shortening velocity) and abolished stimulated actin polymerization. These data suggest that (1) slack length treatment significantly alters the contractile phenotype of arterial tissue, and (2) slack length treatment is a model to study acute phenotypic modulation of intact arterial smooth muscle.

1.
Stegemann JP, Hong H, Nerem RM: Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol 2005;98:2321-2327.
2.
Kawai-Kowase K, Owens GK: Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 2007;292:C59-C69.
3.
Williams B: Mechanical influences on vascular smooth muscle cell function. J Hypertens 1998;16:1921-1929.
4.
Ratz PH, Hai C-M, Murphy RA: Dependence of stress on cross-bridge phosphorylation in vascular smooth muscle. Am J Physiol 1989;256:C96-C100.
5.
Rembold CM, Wardle RL, Wingard CJ, Batts TW, Etter EF, Murphy RA: Cooperative attachment of cross bridges predicts regulation of smooth muscle force by myosin phosphorylation. Am J Physiol Cell Physiol 2004;287:C594-C602.
6.
Horowitz A, Menice CB, Laporte R, Morgan KG: Mechanisms of smooth muscle contraction. Physiol Rev 1996;76:967-1003.
7.
Murphy RA, Rembold CM: The latch-bridge hypothesis of smooth muscle contraction. Can J Physiol Pharmacol 2005;83:857-864.
8.
Somlyo AP, Somlyo AV: Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (Lond) 2000;522:177-185.
9.
Etter EF, Eto M, Wardle RL, Brautigan DL, Murphy RA: Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J Biol Chem 2001;276:34681-34685.
10.
Rembold CM, Tejani AD, Ripley ML, Han S: Paxillin phosphorylation, actin polymerization, noise temperature, and the sustained phase of swine carotid artery contraction. Am J Physiol Cell Physiol 2007;293:C993-C1002.
11.
Tejani AD, Rembold CM: Force augmentation and stimulated actin polymerization in swine carotid artery. Am J Physiol 2010;298:C182-C190.
12.
Gunst SJ, Zhang WW: Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol 2008;295:C576-C587.
13.
Gerthoffer WT: Actin cytoskeletal dynamics in smooth muscle contraction. Can J Physiol Pharmacol 2005;83:851-856.
14.
Tang DD, Zhang WW, Gunst SJ: The adapter protein CrkII regulates neuronal Wiskott-Aldrich syndrome protein, actin polymerization, and tension development during contractile stimulation of smooth muscle. J Biol Chem 2005;280:23380-23389.
15.
Zhao R, Du L, Huang Y, Wu Y, Gunst SJ: Actin depolymerization factor/cofilin activation regulates actin polymerization and tension development in canine tracheal smooth muscle. J Biol Chem 2008;283:36522-36531.
16.
Tejani AD, Walsh MP, Rembold CM: Tissue length modulates ‘stimulated actin polymerization, force augmentation, and the rate of swine carotid arterial contraction. Am J Physiol Cell Physiol 2011;301:C1470-C1478.
17.
Bamburg JR, McGough A, Ono S: Putting a new twist on actin: ADF/cofilins modulate actin dynamics. Trend Cell Biol 1999;9:364-370.
18.
Rembold CM, Murphy RA: Myoplasmic [Ca2+] determines myosin phosphorylation in agonist-stimulated swine arterial smooth muscle. Circ Res 1988;63:593-603.
19.
Wingard CJ, Browne AK, Murphy RA: Dependence of force on length at constant cross-bridge phosphorylation in the swine carotid media. J Physiol (Lond) 1995;488:729-739.
20.
Rembold CM, O'Connor MJ, Clarkson M, Wardle RL, Murphy RA: HSP20 phosphorylation in nitroglycerin- and forskolin-induced sustained reductions in swine carotid media tone. J Appl Physiol 2001;91:1460-1466.
21.
Fabry B, Maksym GN, Shore SA, Moore PE, Panettieri RA, Butler JP, Fredberg JJ: Signal transduction in smooth muscle - selected contribution: time course and heterogeneity of contractile responses in cultured human airway smooth muscle cells. J Appl Physiol 2001;91:986-994.
22.
Fabry B, Maksym GN, Butler JP, Glogauer M, Navajas D, Fredberg JJ: Scaling the microrheologoy of living cells. Phys Rev Lett 2001;87:148102.
23.
Rembold CM: Force suppression and the crossbridge cycle in swine carotid artery. Am J Physiol Cell Physiol 2007;293:1003-1009.
24.
Peltier HJ, Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008;14:844-852.
25.
Cheng YH, Liu XJ, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo YQ, Delphin ES, Zhang CX: MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158-166.
26.
Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460:705-710.
27.
Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T: Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009;119:2634-2647.
28.
Small EM, Frost RJA, Olson EN: MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010;121:1022-1032.
29.
Mohamed JS, Lopez MA, Boriek AM: Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3 beta. J Biol Chem 2010;285:29336-29347.
30.
Leeper NJ, Raiesdana A, Kojima Y, Chun HY, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM: MicroRNA-26a is a novel regulator of vascular smooth muscle function. J Cell Physiol 2010;226:1035-1043.
31.
Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang Z-P, Li J, Shi Z, Kilsdonk EPC, Gui Y, Wang D-Z, Zheng X-F: Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 2011;31:368-375.
32.
Xie C, Huang H, Sun X, Guo Y, Hamblin M, Richie RP, Garcia-Barrio MT, Zhang J, Chen YE: MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev 2011;20:205-210.
33.
Sun S, Zheng B, Han M, Fang X, Li H, Miao S, Su M, Han Y, Shi H, Wen J: miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011;12:56-62.
34.
Lindqvist A, Nordstroem I, Malmqvist U, Nordenfelt P, Hellstrand P: Long-term effects of Ca2+ on structure and contractility of vascular smooth muscle. Am J Physiol Cell Physiol 1999;277:C64-C73.
35.
Demey JGR, Uitendaal MP, Boonen HCM, Vrijdag MJJF, Daemen MJAP, Struykerboudier HAJ: Acute and long-term effects of tissue culture on contractile reactivity in renal arteries of the rat. Circ Res 1989;65:1125-1135.
36.
Guibert C, Savineau JP, Crevel H, Marthan R, Rousseau E: Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries. Br J Pharmacol 2005;146:692-701.
37.
Bakker ENTP, van der Meulen ET, Spaan JAE, VanBavel E: Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol Heart Circ Physiol 2000;278:H1233-H1240.
38.
Bakker ENTP, Matlung HL, Bonta P, de Vries CJ, van Rooijen N, VanBavel E: Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 2008;78:341-348.
39.
Bakker ENTP, van der Meulen ET, van den Berg BM, Everts V, Spaan JAE, VanBavel E: Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 2002;39:12-20.
40.
Ceiler DL, Nelissen-Vrancken HJMG, Smits JFM, De Mey JGR: Pressure but not angiotensin II-induced increases in wall mass or tone influences static and dynamic aortic mechanics. J Hypertens 1999;17:1109-1116.
41.
Buus CL, Pourageaud F, Fazzi GE, Janssen G, Mulvany MJ, De Mey JGR: Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res 2001;89:180-186.
42.
Wesselman JPM, Kuijs R, Hermans JJR, Janssen GMJ, Fazzi GE, van Essen H, Evelo CTA, Struijker-Boudier HAJ, De Mey JGR: Role of the RhoA/Rho kinase system in flow-related remodeling of rat mesenteric small arteries in vivo. J Vasc Res 2004;41:277-290.
43.
Wu Y, Huang YL, Herring BP, Gunst SJ: Integrin-linked kinase regulates smooth muscle differentiation marker gene expression in airway tissue. Am J Physiol Lung Cell Mol Physiol 2008;295:L988-L997.
44.
Bakker ENTP, Sorop O, Spaan JAE, VanBavel E: Remodeling of resistance arteries in organoid culture is modulated by pressure and pressure pulsation and depends on vasomotion. Am J Physiol Heart Circ Physiol 2004;286:H2052-H2056.
45.
Jin L, Yoshida T, Ho RY, Owens GK, Somlyo AV: The actin-associated protein palladin is required for development of normal contractile properties of smooth muscle cells derived from embryoid bodies. J Biol Chem 2009;284:2121-2130.
46.
Tran T, Ens-Blackie K, Rector ES, Stelmack GL, McNeill KD, Tarone G, Gerthoffer WT, Unruh H, Halayko AJ: Laminin-binding integrin alpha 7 is required for contractile phenotype expression by human airway myocytes. Am J Respir Cell Mol Biol 2007;37:668-680.
47.
Beamish JA, Fu AY, Choi A, Haq NA, Kottke-Marchant K, Marchant RE: The influence of RGD-bearing hydrogels on the reexpression of contractile smooth muscle phenotype. Biomaterials 2009;30:4127-4135.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.